tirzepatide journal club SURMOUNT-1 Trial In the SURMOUNT-1 trial (published

Protein preserves muscle during weight loss, supports satiety between meals, and provides the amino acid building blocks that your body needs for repair and maintenance

In the SURMOUNT-1 clinical trial, patients taking the highest dose (15 mg) of tirzepatide lost about 21% of their body weight over 72 weeks

Micronutrient fortification: Shakes fortified with vitamins and minerals can help address potential nutritional gaps during periods of restricted intake

A history of pancreatitis Pancreatitis (inflammation of the pancreas) has been reported in people on GLP-1 medications, though its uncommon and the absolute risk increase is small